Chengdu Kanghua Biological Products Capital Reinvestment Ratio
Chengdu Kanghua Biological Products capital reinvestment ratio. Chengdu Kanghua Biological Products (300841) has a Capital Reinvestment Ratio of 0.16x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥92.89 Million) in capital expenditures (CN¥14.49 Million). Check Chengdu Kanghua Biological Products total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Chengdu Kanghua Biological Products (2015–2024)
Capital reinvestment ratio of Chengdu Kanghua Biological Products from 2015 to 2024. This chart tracks Chengdu Kanghua Biological Products's Capital Reinvestment Ratio across 10 annual periods. Also explore net asset momentum of Chengdu Kanghua Biological Products to track the company's year-over-year net asset growth rate.
Chengdu Kanghua Biological Products Capital Reinvestment Ratio by Year (2015–2024)
Chengdu Kanghua Biological Products capital reinvestment ratio by year from 2015 to 2024. For the full cash flow conversion analysis, see how efficiently does Chengdu Kanghua Biological Products generate cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.25x | CN¥572.24 Million | CN¥144.30 Million | ▼ -8.0% |
| 2023 | 0.27x | CN¥573.98 Million | CN¥157.27 Million | ▼ -87.3% |
| 2022 | 2.15x | CN¥194.99 Million | CN¥419.23 Million | ▼ -11.0% |
| 2021 | 2.42x | CN¥130.33 Million | CN¥314.94 Million | ▲ +558.3% |
| 2020 | 0.37x | CN¥369.56 Million | CN¥135.67 Million | ▲ +179.1% |
| 2019 | 0.13x | CN¥182.73 Million | CN¥24.04 Million | ▼ -78.2% |
| 2018 | 0.60x | CN¥57.35 Million | CN¥34.58 Million | ▲ +1096.9% |
| 2017 | 0.05x | CN¥89.96 Million | CN¥4.53 Million | ▼ -92.8% |
| 2016 | 0.70x | CN¥2.64 Million | CN¥1.86 Million | ▲ +48.7% |
| 2015 | 0.47x | CN¥6.51 Million | CN¥3.07 Million | — |